Fair Market Value Reviews

PYA GatesMoore’s valuation experts provide fair market value (FMV) and commercial reasonableness opinions for a wide range of financial arrangements entered into by physicians, hospitals, and other healthcare entities.  Most often, our reviews are used to help ensure that compensation arrangements comply with the Stark law, the anti-kickback statute, and other regulations governing transactions in the healthcare industry.

Fair market value must be determined on a case by case basis by looking at the facts and circumstances of a proposed deal as well as the relevant market for the services or products being provided.  Whether we are issuing an opinion related to the employment terms being offered to a single physician or reviewing a hospital service line management arrangement, we provide the client with a comprehensive review that incorporates the most current market data available and is supported by our knowledge of the healthcare market and extensive expertise working with healthcare professionals.

Our staff includes consultants and appraisers with specialized valuation and compensation experience and a focus on the medical service industry.  We have certifications from recognized professional valuation associations such as the American Institute of Certified Public Accountants (AICPA), the National Association of Certified Valuation Analysts (NACVA), the American Society of Appraisers (ASA), and the Institute of Business Appraisers (IBA).  Our collective experience includes consulting and valuation work involving nearly every physician specialty and type of healthcare business.

EXAMPLES OF AGREEMENTS REVIEWED

  • Employed physician compensation
  • Physician personal services such as: medical directorships, call coverage compensation consulting services, and professional clinical services, such as diagnostic interpretation
  • Clinical co-management and other management services
  • Space, equipment, & staff leasing
  • Physician recruitment incentives
  • Non-monetary compensation
  • Isolated transactions such as medical practice acquisitions/divestitures
  • Quality incentive programs